Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicenter Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)

NCT04528706 is registered in ClinicalTrials.gov with Minoryx Therapeutics, S.L. as lead sponsor.

NCT NCT04528706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04528706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicenter Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)
Lead sponsor
Minoryx Therapeutics, S.L.
Phase
Phase 2
Overall status
Unknown status
Start date
September 13, 2019
Completion date
December 31, 2023
Enrollment
13 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral adrenoleukodystrophy